Tofacitinib for Maintenance Therapy in Patients With Active Ulcerative Colitis in the Phase 3 OCTAVE Sustain Trial: Results by Local and Central Endoscopic Assessments

被引:4
|
作者
Feagan, Brian G. [1 ]
Vermeire, Severine [2 ]
Sandborn, William J. [3 ]
Reinisch, Walter [4 ]
Panes, Julian [5 ]
Tarabar, Dino [6 ]
Su, Chinyu [7 ]
Niezychowski, Wojciech [7 ]
Zhang, Haiying [7 ]
Friedman, Gary S. [7 ]
Woodworth, Deborah A. [7 ]
Sands, Bruce E. [8 ]
机构
[1] Western Univ, Robarts Res Inst, London, ON, Canada
[2] Univ Hosp Leuven, Leuven, Vlaams Brabant, Belgium
[3] Univ Calif San Diego, La Jolla, CA 92093 USA
[4] Med Univ Vienna, Hamilton, ON, Canada
[5] Hosp Clin Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain
[6] Mil Med Acad, Clin Gastroenterol & Hepatol, Belgrade, Serbia
[7] Pfizer Inc, Collegeville, PA USA
[8] Icahn Sch Med Mt Sinai, Dr Henry D Janowitz Div Gastroenterol, New York, NY 10029 USA
来源
关键词
D O I
10.14309/00000434-201710001-00607
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
607
引用
收藏
页码:S329 / S329
页数:1
相关论文
共 50 条
  • [1] Tofacitinib for Induction Therapy in Patients with Active Ulcerative Colitis in Two Phase 3 Clinical Trials: Results by Local and Central Endoscopic Assessments
    Feagan, Brian
    Vermeire, Severine
    Sandborn, William J.
    Reinisch, Walter
    Tarabar, Dino
    Su, Chinyu
    Niezychowski, Wojciech
    Zhang, Haiying
    Woodworth, Deborah
    Yu, Dahong
    Sands, Bruce
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S319 - S320
  • [2] Tofacitinib as a maintenance therapy in patients with ulcerative colitis stratified by OCTAVE Sustain baseline Mayo endoscopic subscore
    Scott D. Lee
    Jessica R. Allegretti
    Flavio Steinwurz
    Susan B. Connelly
    Nervin Lawendy
    Jerome Paulissen
    Krisztina B. Gecse
    [J]. BMC Gastroenterology, 23
  • [3] Tofacitinib as a maintenance therapy in patients with ulcerative colitis stratified by OCTAVE Sustain baseline Mayo endoscopic subscore
    Lee, Scott D.
    Allegretti, Jessica R.
    Steinwurz, Flavio
    Connelly, Susan B.
    Lawendy, Nervin
    Paulissen, Jerome
    Gecse, Krisztina B.
    [J]. BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [4] Evaluation of the Efficacy of Tofacitinib as Maintenance Therapy in Patients With Ulcerative Colitis Stratified by OCTAVE Sustain Baseline Endoscopic Subscore
    Lee, Scott D.
    Allegretti, Jessica R.
    Steinwurz, Flavio
    Connelly, Susan B.
    Lawendy, Nervin
    Paulissen, Jerome
    Gecse, Krisztina B.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S340 - S340
  • [5] Evaluation of the efficacy of tofacitinib as maintenance therapy in patients with Ulcerative Colitis stratified by OCTAVE Sustain baseline endoscopic subscore
    Lee, S. D.
    Allegretti, J. R.
    Steinwurz, F.
    Connelly, S. B.
    Lawendy, N.
    Paulissen, J.
    Gecse, K. B.
    [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 : S094 - S095
  • [6] Agreement between local and central reading of endoscopic disease activity in ulcerative colitis: results from the tofacitinib OCTAVE trials
    Feagan, Brian G.
    Khanna, Reena
    Sandborn, William J.
    Vermeire, Severine
    Reinisch, Walter
    Su, Chinyu
    Salese, Leonardo
    Fan, Haiyun
    Paulissen, Jerome
    Woodworth, Deborah A.
    Niezychowski, Wojciech
    Sands, Bruce E.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (11-12) : 1442 - 1453
  • [7] Time to Loss of Efficacy Following Tofacitinib Interruption in Patients With Ulcerative Colitis: Results From OCTAVE Sustain
    Dubinsky, Marla C.
    Clarke, Kofi
    Klaus, Jochen
    Bouhnik, Yoram
    Soonasra, Arif
    Thorpe, Andrew J.
    Zhang, Haiying
    Friedman, Gary S.
    Woodworth, Deborah A.
    Lawendy, Nervin
    Su, Chinyu
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S405 - S406
  • [8] Maintenance of Remission With Tofacitinib Therapy in Patients With Ulcerative Colitis
    Colombel, Jean-Frederic
    Osterman, Mark T.
    Thorpe, Andrew J.
    Salese, Leonardo
    Nduaka, Chudy I.
    Zhang, Haiying
    Lawendy, Nervin
    Friedman, Gary S.
    Quirk, Daniel
    Su, Chinyu
    Reinisch, Walter
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (01) : 116 - +
  • [9] Efficacy and safety of oral tofacitinib as maintenance therapy in patients with moderate to severe ulcerative colitis: results from a phase 3 randomised controlled trial
    Sandborn, W. J.
    Sands, B. E.
    Danese, S.
    D'Haens, G. R.
    Vermeire, S.
    Schreiber, S.
    Feagan, B.
    Reinisch, W.
    Friedman, G.
    Woodworth, D.
    Zhang, H.
    Lawendy, N.
    Niezychowski, W.
    Su, C.
    Panes, J.
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S19 - S20
  • [10] EFFICACY AND SAFETY OF ORAL TOFACITINIB AS MAINTENANCE THERAPY IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS: RESULTS FROM A PHASE 3 RANDOMIZED CONTROLLED TRIAL
    Sandborn, William J.
    Sands, Bruce E.
    Danese, Silvio
    D'Haens, Geert R.
    Vermeire, Severine
    Schreiber, Stefan
    Feagan, Brian G.
    Reinisch, Walter
    Friedman, Gary
    Woodworth, Deborah A.
    Zhang, Haiying
    Lawendy, Nervin
    Niezychowski, Wojciech
    Su, Chinyu
    Panes, Julian
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S199 - S199